Piper Sandler Maintains Glaukos at Overweight, Raises Target to $240
Piper Sandler maintained its Overweight rating on Glaukos and raised its price target to $240 from $195.
Piper Sandler maintained its Overweight rating on Glaukos and raised its price target to $240 from $195.